AbbVie
ABBV
#30
Rank
C$445.80 B
Marketcap
$252.27
Share price
2.37%
Change (1 day)
24.46%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total debt

Total debt on the balance sheet as of September 2024 : C$102.12 Billion

According to AbbVie's latest financial reports the company's total debt is C$102.12 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

AbbVie - Total debt on balance sheet (from 2011 to 2024)

Total debt by year

Year Total debt Change
2023-12-31C$78.76 B-8.26%
2022-12-31C$85.85 B-12.15%
2021-12-31C$97.72 B-10.93%
2020-12-31C$109.72 B25.91%
2019-12-31C$87.15 B58.71%
2018-12-31C$54.91 B16.88%
2017-12-31C$46.98 B-5.11%
2016-12-31C$49.51 B12.69%
2015-12-31C$43.93 B152.78%
2014-12-31C$17.38 B10.9%
2013-12-31C$15.67 B0.57%
2012-12-31C$15.58 B31818.17%
2011-12-31C$48.82 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
C$95.71 B-6.28%๐Ÿ‡บ๐Ÿ‡ธ USA
C$73.85 B-27.69%๐Ÿ‡บ๐Ÿ‡ธ USA
C$44.71 B-56.22%๐Ÿ‡บ๐Ÿ‡ธ USA
C$86.77 B-15.03%๐Ÿ‡บ๐Ÿ‡ธ USA
C$33.40 B-67.29%๐Ÿ‡บ๐Ÿ‡ธ USA
C$9.55 B-90.64%๐Ÿ‡บ๐Ÿ‡ธ USA
C$30.87 B-69.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
C$45.34 B-55.60%๐Ÿ‡ฌ๐Ÿ‡ง UK
C$0.36 B-99.65%๐Ÿ‡บ๐Ÿ‡ธ USA